RNA oxidation and iron levels in patients with diabetes

Vanja Cejvanovic; Laura Kofoed Kjær; Helle Kirstine Mørup Bergholdt; Trine Henriksen; Allan Weimann; Christina Ellervik; Henrik Enghusen Poulsen

doi:10.1016/j.freeradbiomed.2018.10.420

RNA oxidation and iron levels in patients with diabetes

Vanja Cejvanovic^*, Laura Kofoed Kjær, Helle Kirstine Mørup Bergholdt, Trine Henriksen, Allan Weimann, Christina Ellervik, Henrik Enghusen Poulsen

^*Corresponding author for this work

Department of Clinical Medicine

5 Citations (Scopus)

Abstract

Aim: The urinary biomarker for oxidative stress to RNA, 8-oxo-7,8-dihydro-guanosine (8-oxoGuo) is associated with mortality in patients with type 2 diabetes. Iron has also been linked to diabetes. In individuals with untreated hereditary iron overload it has been observed that 8-oxoGuo was higher compared to controls. In the current study, we hypothesized that 8-oxoGuo was associated with diagnosis of diabetes, and that iron confounded this association. Methods: Participants from a general Danish population were included in the study (n = 3567). UPLC-MS/MS method was used for 8-oxoGuo (nmol/mmol creatinine) measurement in spot urine. Iron biomarkers included total plasma iron, ferritin, transferrin saturation (TS) and transferrin. Results: 8-oxoGuo was 17% higher in diabetes patients (n = 208) compared to non-diabetes controls. Unadjusted logistic regression model showed an odds ratio of diabetes of 1.38 (95%CI:1.21–1.57, P < 0.0001) per unit increase of 8-oxoGuo. When the model was adjusted for possible confounders the odds ratio was 1.09 (95%CI:0.94–1.26, P = 0.24). When additional adjustment was performed including ferritin, TS, or transferrin, respectively, the OR were 1.14 (95%CI:0.97–1.33, P = 0.09), 1.10 (95%CI: 0.95–1.28, P = 0.18), and 1.17 (95%CI:1.01–1.38, P = 0.04). Conclusions: Our study indicates that 8-oxoGuo is higher in diabetes patients. The lack of association between 8-oxoGuo and diabetes in the adjusted model may be due to the cross-sectional design including post-treatment bias. Our data did not show consistent effect of all iron biomarkers in relation to diabetes. Most likely, the iron biomarkers were affected by inflammation thus not reflecting true iron levels.

Original language	English
Journal	Free Radical Biology and Medicine
Volume	129
Pages (from-to)	532-536
Number of pages	5
ISSN	0891-5849
DOIs	https://doi.org/10.1016/j.freeradbiomed.2018.10.420
Publication status	Published - 2018

Keywords

8-oxo-7,8-dihydro-2′-deoxyguanosine
8-oxo-7,8-dihydro-guanosine
Diabetes
Iron
Oxidative modification
Oxidative stress

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.freeradbiomed.2018.10.420

Cite this

@article{5b344ac34f324897beb6f60aa583be29,

title = "RNA oxidation and iron levels in patients with diabetes",

abstract = "Aim: The urinary biomarker for oxidative stress to RNA, 8-oxo-7,8-dihydro-guanosine (8-oxoGuo) is associated with mortality in patients with type 2 diabetes. Iron has also been linked to diabetes. In individuals with untreated hereditary iron overload it has been observed that 8-oxoGuo was higher compared to controls. In the current study, we hypothesized that 8-oxoGuo was associated with diagnosis of diabetes, and that iron confounded this association. Methods: Participants from a general Danish population were included in the study (n = 3567). UPLC-MS/MS method was used for 8-oxoGuo (nmol/mmol creatinine) measurement in spot urine. Iron biomarkers included total plasma iron, ferritin, transferrin saturation (TS) and transferrin. Results: 8-oxoGuo was 17% higher in diabetes patients (n = 208) compared to non-diabetes controls. Unadjusted logistic regression model showed an odds ratio of diabetes of 1.38 (95%CI:1.21–1.57, P < 0.0001) per unit increase of 8-oxoGuo. When the model was adjusted for possible confounders the odds ratio was 1.09 (95%CI:0.94–1.26, P = 0.24). When additional adjustment was performed including ferritin, TS, or transferrin, respectively, the OR were 1.14 (95%CI:0.97–1.33, P = 0.09), 1.10 (95%CI: 0.95–1.28, P = 0.18), and 1.17 (95%CI:1.01–1.38, P = 0.04). Conclusions: Our study indicates that 8-oxoGuo is higher in diabetes patients. The lack of association between 8-oxoGuo and diabetes in the adjusted model may be due to the cross-sectional design including post-treatment bias. Our data did not show consistent effect of all iron biomarkers in relation to diabetes. Most likely, the iron biomarkers were affected by inflammation thus not reflecting true iron levels.",

keywords = "8-oxo-7,8-dihydro-2′-deoxyguanosine, 8-oxo-7,8-dihydro-guanosine, Diabetes, Iron, Oxidative modification, Oxidative stress",

author = "Vanja Cejvanovic and Kj{\ae}r, {Laura Kofoed} and {M{\o}rup Bergholdt}, {Helle Kirstine} and Trine Henriksen and Allan Weimann and Christina Ellervik and Poulsen, {Henrik Enghusen}",

year = "2018",

doi = "10.1016/j.freeradbiomed.2018.10.420",

language = "English",

volume = "129",

pages = "532--536",

journal = "Free Radical Biology and Medicine",

issn = "0891-5849",

publisher = "Elsevier",

}

TY - JOUR

T1 - RNA oxidation and iron levels in patients with diabetes

AU - Cejvanovic, Vanja

AU - Kjær, Laura Kofoed

AU - Mørup Bergholdt, Helle Kirstine

AU - Henriksen, Trine

AU - Weimann, Allan

AU - Ellervik, Christina

AU - Poulsen, Henrik Enghusen

PY - 2018

Y1 - 2018

N2 - Aim: The urinary biomarker for oxidative stress to RNA, 8-oxo-7,8-dihydro-guanosine (8-oxoGuo) is associated with mortality in patients with type 2 diabetes. Iron has also been linked to diabetes. In individuals with untreated hereditary iron overload it has been observed that 8-oxoGuo was higher compared to controls. In the current study, we hypothesized that 8-oxoGuo was associated with diagnosis of diabetes, and that iron confounded this association. Methods: Participants from a general Danish population were included in the study (n = 3567). UPLC-MS/MS method was used for 8-oxoGuo (nmol/mmol creatinine) measurement in spot urine. Iron biomarkers included total plasma iron, ferritin, transferrin saturation (TS) and transferrin. Results: 8-oxoGuo was 17% higher in diabetes patients (n = 208) compared to non-diabetes controls. Unadjusted logistic regression model showed an odds ratio of diabetes of 1.38 (95%CI:1.21–1.57, P < 0.0001) per unit increase of 8-oxoGuo. When the model was adjusted for possible confounders the odds ratio was 1.09 (95%CI:0.94–1.26, P = 0.24). When additional adjustment was performed including ferritin, TS, or transferrin, respectively, the OR were 1.14 (95%CI:0.97–1.33, P = 0.09), 1.10 (95%CI: 0.95–1.28, P = 0.18), and 1.17 (95%CI:1.01–1.38, P = 0.04). Conclusions: Our study indicates that 8-oxoGuo is higher in diabetes patients. The lack of association between 8-oxoGuo and diabetes in the adjusted model may be due to the cross-sectional design including post-treatment bias. Our data did not show consistent effect of all iron biomarkers in relation to diabetes. Most likely, the iron biomarkers were affected by inflammation thus not reflecting true iron levels.

AB - Aim: The urinary biomarker for oxidative stress to RNA, 8-oxo-7,8-dihydro-guanosine (8-oxoGuo) is associated with mortality in patients with type 2 diabetes. Iron has also been linked to diabetes. In individuals with untreated hereditary iron overload it has been observed that 8-oxoGuo was higher compared to controls. In the current study, we hypothesized that 8-oxoGuo was associated with diagnosis of diabetes, and that iron confounded this association. Methods: Participants from a general Danish population were included in the study (n = 3567). UPLC-MS/MS method was used for 8-oxoGuo (nmol/mmol creatinine) measurement in spot urine. Iron biomarkers included total plasma iron, ferritin, transferrin saturation (TS) and transferrin. Results: 8-oxoGuo was 17% higher in diabetes patients (n = 208) compared to non-diabetes controls. Unadjusted logistic regression model showed an odds ratio of diabetes of 1.38 (95%CI:1.21–1.57, P < 0.0001) per unit increase of 8-oxoGuo. When the model was adjusted for possible confounders the odds ratio was 1.09 (95%CI:0.94–1.26, P = 0.24). When additional adjustment was performed including ferritin, TS, or transferrin, respectively, the OR were 1.14 (95%CI:0.97–1.33, P = 0.09), 1.10 (95%CI: 0.95–1.28, P = 0.18), and 1.17 (95%CI:1.01–1.38, P = 0.04). Conclusions: Our study indicates that 8-oxoGuo is higher in diabetes patients. The lack of association between 8-oxoGuo and diabetes in the adjusted model may be due to the cross-sectional design including post-treatment bias. Our data did not show consistent effect of all iron biomarkers in relation to diabetes. Most likely, the iron biomarkers were affected by inflammation thus not reflecting true iron levels.

KW - 8-oxo-7,8-dihydro-2′-deoxyguanosine

KW - 8-oxo-7,8-dihydro-guanosine

KW - Diabetes

KW - Iron

KW - Oxidative modification

KW - Oxidative stress

U2 - 10.1016/j.freeradbiomed.2018.10.420

DO - 10.1016/j.freeradbiomed.2018.10.420

M3 - Journal article

C2 - 30339885

AN - SCOPUS:85055665497

SN - 0891-5849

VL - 129

SP - 532

EP - 536

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

ER -

RNA oxidation and iron levels in patients with diabetes

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this